Karachi, GlaxoSmithKline Pakistan Limited (GLAXO) reported losses for the nine months ended September 30, 2023, with a before-tax profit of PKR 255.480 million and an after-tax loss of PKR 391.621 million. EPS was negative at PKR -1.23.
Karachi, GlaxoSmithKline Pakistan Limited (GLAXO) reported losses for the nine months ended September 30, 2023, with a before-tax profit of PKR 255.480 million and an after-tax loss of PKR 391.621 million. EPS was negative at PKR -1.23.